Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EPCAM”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableActive Not RecruitingNCT02760849
What this trial is testing

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

Who this might be right for
Deleterious BARD1 Gene MutationDeleterious BRCA1 Gene MutationDeleterious BRCA2 Gene Mutation+11 more
M.D. Anderson Cancer Center 374
Not applicableNot Yet RecruitingNCT07018505
What this trial is testing

EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers

Who this might be right for
Sentinel Lymph NodeBreast CancersMetastases+1 more
Yunnan Cancer Hospital 40
Early research (Phase 1)Study completedNCT04501744
What this trial is testing

M701 (EpCAM and CD3) in Malignant Ascites

Who this might be right for
Malignant AscitesCancer
Wuhan YZY Biopharma Co., Ltd. 35
Not applicableLooking for participantsNCT07026110
What this trial is testing

Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer

Who this might be right for
Lung CancerLung DiseasesLung Neoplasms+2 more
RenJi Hospital 100
Early research (Phase 1)Looking for participantsNCT05808634
What this trial is testing

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Who this might be right for
Advanced Adenocarcinoma
BioAtla, Inc. 168
Testing effectiveness (Phase 2)Study completedNCT00377429
What this trial is testing

Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy

Who this might be right for
Ovarian Cancer
Neovii Biotech 47
Very early researchStudy completedNCT04379999
What this trial is testing

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Who this might be right for
Lynch Syndrome
Fox Chase Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT03146637
What this trial is testing

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Who this might be right for
Advanced Liver Cancer
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT00326885
What this trial is testing

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Who this might be right for
Malignant Ascites
Neovii Biotech 32
Testing effectiveness (Phase 2)WithdrawnNCT04648189
What this trial is testing

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Who this might be right for
Lung CancerSurgeryCirculating Tumor Cell
The Netherlands Cancer Institute
Not applicableNot Yet RecruitingNCT07400263
What this trial is testing

Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors

Who this might be right for
Epithelial Tumors, Malignant
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00352833
What this trial is testing

Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 40
Early research (Phase 1)Looking for participantsNCT05028933
What this trial is testing

IMC001 for Clinical Research on Advanced Digestive System Malignancies

Who this might be right for
Advanced Hepatocellular CarcinomaAdvanced Colorectal CancerAdvanced Gastric Cancer+1 more
Zhejiang University 48
Testing effectiveness (Phase 2)Study completedNCT00464893
What this trial is testing

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 70
Not applicableActive Not RecruitingNCT04009148
What this trial is testing

Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome

Who this might be right for
BRCA-Mutated Ovarian CarcinomaBRIP1 Gene MutationMSH2 A636P+5 more
NYU Langone Health 118
Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Early research (Phase 1)Study completedNCT06386653
What this trial is testing

Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Who this might be right for
Lung CancerOvarian Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)UnknownNCT03563326
What this trial is testing

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

Who this might be right for
Neoplasm, StomachMetastases, NeoplasmNeoplasm Seeding
Jian-Kun Hu 40
Not applicableUnknownNCT05703815
What this trial is testing

EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast

Who this might be right for
Invasive Breast Cancer
Sohag University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05543330
What this trial is testing

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Who this might be right for
Malignant Pleural EffusionsNSCLC Stage IV
Wuhan YZY Biopharma Co., Ltd. 96
Load More Results